Patients with RA ( n = @ ) with moderate disease activity who were receiving stable disease-modifying antirheumatic drug therapy were randomized to drug sequence , receiving either pioglitazone @ mg/day or matching placebo for @ weeks , followed by a @-week washout period and the alternative treatment for @ weeks .